Nighttime fasting may decrease breast cancer risk in women
the ONA take:
According to a recent study published in the journal Cancer Epidemiology, Biomarkers & Prevention, researchers from the University of California, San Diego School of Medicine have found that a reduction in the amount of time spent eating and an increase in overnight fasting decreases glucose levels and may lower the risk of breast cancer among women.
In the study, participants reported eating five times per day with an average fasting of 12 hours during the nighttime. Women who reported longer fasting periods also consumed fewer calories during the day, ate fewer calories after 10 p.m, and had a fewer eating episodes.
Results showed that women who had a longer fasting duration overnight had significantly better glycemic control. In addition, researchers found that each 3 hour increase in overnight fasting was associated with a 4% lower postprandial glucose level.
The researchers note that larger studies are needed to confirm that overnight fasting improves glycemic control and reduces breast cancer risk.
An increase in overnight fasting decreases glucose levels and may lower the risk of breast cancer among women.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Mammograms (Fact Sheet)
- Tissue Biobank Procurement Consent Should Include Discussion of Confidentiality Risks
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|